Lori Burton

Development of a precipitation-resistant solution formulation to increase in vivo exposure of a poorly water-soluble compound.

Keyur R. Shah, Christine S. Huang, S. Zhou, 2012, International journal of pharmaceutics.

An Intercompany Perspective on Compatibility and In-Use Stability Studies to Enable Administration of Biopharmaceutical Drug Products.

Elaine S E Stokes, Brittney J. Mills, Kevin Muthurania, 2021, Journal of pharmaceutical sciences.

Sensitive fluorescence-based method for the rapid determination of polysorbate-80 content in therapeutic monoclonal antibody products

Lori Burton, Monica L. Adams, Songyan Zheng, 2015, Pharmaceutical development and technology.

Financial Statements with Environmental Concerns: An Exploratory Study of the Impact on the Auditor's Role and Responsibilities

Lori Burton, 1994 .

An Industry Perspective on the Challenges of Using Closed System Transfer Devices with Biologics and Communication Guidance to Healthcare Professionals.

C. Zamiri, Lori Burton, Twinkle R. Christian, 2021, Journal of pharmaceutical sciences.

An Industry Perspective on Compatibility Assessment of Closed System Drug-Transfer Devices for Biologics.

Richard J. Galas, Ahmed Besheer, C. Zamiri, 2020, Journal of pharmaceutical sciences.

Sustained release subcutaneous delivery of BMS-686117, a GLP-1 receptor peptide agonist, via a zinc adduct.

Feng Qian, M. Hussain, Sridhar Desikan, 2009, International journal of pharmaceutics.